GENEVA, Oct. 1 -- ONCOLINC THERAPEUTICS INC. filed a patent application (CA2025/050355) for “METHODS AND COMPOSITIONS TARGETING LINC01929 TO INCREASE ANTIGEN PRESENTATION”. With publication no. WO/2026/188318, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....